Concepedia

Publication | Closed Access

Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma

DOI

255

Citations

10

References

2023

Year

Yohann Loriot, Nobuaki Matsubara, Se Hoon Park, Robert Huddart, Earle F. Burgess, Nadine Houédé, Séverine Banek, Valentina Guadalupi, Ja Hyeon Ku, Begoña P. Valderrama,
New England Journal of Medicine

Abstract

Erdafitinib therapy resulted in significantly longer overall survival than chemotherapy among patients with metastatic urothelial carcinoma and <i>FGFR</i> alterations after previous anti-PD-1 or anti-PD-L1 treatment. (Funded by Janssen Research and Development; THOR ClinicalTrials.gov number, NCT03390504.).

References

YearCitations

Page 1